Insulet Corporation (PODD) Announces Strategic Expansion and Supply Agreement Update
Insulet Corporation (NASDAQ:PODD) is one of the best medical technology stocks to invest in.
Insulet Corp (PODD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 459,115 | $130,498,891 | +162% | 0.07% |
| 2. | GLG Partners Noam Gottesman | 434,568 | $123,521,608 | -6% | 0.21% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 324,717 | $92,297,563 | +16% | 0.08% |
| 4. | Renaissance Technologies Jim Simons | 303,283 | $86,205,160 | -23% | 0.13% |
| 5. | Millennium Management Israel Englander | 232,949 | $66,213,424 | +16% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $311.73 | 962 | $299,884.26 | 4,591 | 2025-12-05 | Filing | |
| $206.00 | 100 | $20,600.00 | 13,314 | 2024-08-29 | Filing | |
| $168.92 | 1 | $168.92 | 4,032 | 2023-09-19 | Filing | |
| $181.41 | 5,550 | $1,006,825.50 | 34,177 | 2023-08-28 | Filing | |
| $304.75 | 3,300 | $1,005,675.00 | 12,221 | 2023-05-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $293.09 | 1,851 | $542,509.59 | 2,158 | 2025-12-15 | Filing | |
| $347.49 | 687 | $238,725.63 | 3,456 | 2025-09-08 | Filing | |
| $348.81 | 797 | $278,001.57 | 3,890 | 2025-09-08 | Filing | |
| $332.23 | 4,263 | $1,416,296.49 | 16,736 | 2025-08-21 | Filing | |
| $320.00 | 1,343 | $429,760.00 | 4,143 | 2025-08-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,701,472 | $2,473,306,401 | 0.04% | |
| 2. | 6,578,887 | $1,869,982,939 | 0.03% | |
| 3. | 6,325,354 | $1,797,918,592 | 0.09% | |
| 4. | 4,408,972 | $1,253,223,507 | 0.23% | |
| 5. | 3,155,489 | $896,916,193 | 0.03% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Insulet Corporation (PODD): A Bull Case Theory
We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD.
Reasons Why Hedge Funds Favor Insulet Corp (PODD)
As of the close of play on January 28, Insulet Corporation (NASDAQ:PODD) carried a highly bullish consensus view.
12 Best Medical Devices Stocks to Invest In According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
Bernstein Reduces Firm’s PT on Insulet (PODD) Stock
Insulet Corporation (NASDAQ:PODD) is one of the Best Fundamental Stocks to Buy According to Analysts.
13 Best Fundamental Stocks to Buy According to Analysts
Goldman Sachs Research anticipates that the US stocks will post a fourth-straight year of gains in 2026.
What Provides InsuletCorp. (PODD) With a Durable Competitive Advantage?
Parnassus Investments, an investment management company, released the “Parnassus Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Truist Cuts Insulet (PODD) PT but Maintains Buy as Top MedTech Pick for 2026
Insulet Corporation (NASDAQ:PODD) is one of the best growth stocks to buy in 2026.
10 Best Growth Stocks to Buy in 2026
On December 10, Meghan Shue, Wilmington Trust chief investment strategist, appeared on CNBC's 'The Exchange'.
Hedge Fund Resource Center Billionaire Hedge Funds
